---
title: "Acadia rises as EU backs Rett syndrome therapy"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290985890.md"
description: "Acadia rises as EU backs Rett syndrome therapy"
datetime: "2026-06-26T15:30:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290985890.md)
  - [en](https://longbridge.com/en/news/290985890.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290985890.md)
---

# Acadia rises as EU backs Rett syndrome therapy


### Related Stocks

- [ACAD.US](https://longbridge.com/en/quote/ACAD.US.md)

## Related News & Research

- [ACADIA Pharmaceuticals (ACAD) Receives a Hold from Stifel Nicolaus](https://longbridge.com/en/news/293825186.md)
- [How FDA Fast Track For Remlifanserin In Alzheimer’s Psychosis At ACADIA (ACAD) Has Changed Its Investment Story](https://longbridge.com/en/news/294004149.md)
- [ACADIA issues press release on FDA Fast Track designation for remlifanserin in Alzheimer’s disease psychosis](https://longbridge.com/en/news/293219067.md)
- [Kyverna signs commercial manufacturing, supply deal with ElevateBio for miv-cel CAR-T therapy](https://longbridge.com/en/news/293928704.md)
- [10:31 ETFood Allergy Market on the Rise: 5 Emerging Therapies to Watch | DelveInsight](https://longbridge.com/en/news/293947697.md)